0001209191-18-053533.txt : 20181002 0001209191-18-053533.hdr.sgml : 20181002 20181002213532 ACCESSION NUMBER: 0001209191-18-053533 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180928 FILED AS OF DATE: 20181002 DATE AS OF CHANGE: 20181002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASTRAZENECA PLC CENTRAL INDEX KEY: 0000901832 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38670 FILM NUMBER: 181103591 BUSINESS ADDRESS: STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB2 0AA BUSINESS PHONE: 011 44 20 7304 5000 MAIL ADDRESS: STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB2 0AA FORMER NAME: FORMER CONFORMED NAME: ZENECA GROUP PLC DATE OF NAME CHANGE: 19930422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASTRAZENECA AB CENTRAL INDEX KEY: 0000928966 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38670 FILM NUMBER: 181103592 BUSINESS ADDRESS: STREET 1: V?STRA M?LAREHAMNEN 9 CITY: S?DERT?LJE STATE: V7 ZIP: SE-151 85 BUSINESS PHONE: 0044 (0) 20 7604 800 MAIL ADDRESS: STREET 1: V?STRA M?LAREHAMNEN 9 CITY: S?DERT?LJE STATE: V7 ZIP: SE-151 85 FORMER NAME: FORMER CONFORMED NAME: ASTRA AB DATE OF NAME CHANGE: 19981116 FORMER NAME: FORMER CONFORMED NAME: ASTRA AKTIEBOLAG DATE OF NAME CHANGE: 19960718 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Entasis Therapeutics Holdings Inc. CENTRAL INDEX KEY: 0001724344 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824592913 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 810-0120 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Entasis Therapeutics Ltd DATE OF NAME CHANGE: 20171204 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-28 0 0001724344 Entasis Therapeutics Holdings Inc. ETTX 0000901832 ASTRAZENECA PLC 1 FRANCIS CRICK AVENUE CAMBRIDGE X0 CB2 0AA UNITED KINGDOM 0 0 1 0 0000928966 ASTRAZENECA AB C/O ASTRAZENECA PLC 1 FRANCIS CRICK AVENUE CAMBRIDGE X0 CB2 0AA UNITED KINGDOM 0 0 1 0 Common Stock 2018-09-28 4 C 0 1918185 A 1918189 I See Footnote Common Stock 2018-09-28 4 P 0 246666 15.00 A 2164855 I See Footnote Series A Preferred Stock 2018-09-28 4 C 0 33499900 0.00 D Common Stock 1616166 0 I See Footnote This number includes 302,019 shares of Common Stock received upon the conversion of the Issuer's Series A Preferred Stock as payment of accrued dividends through September 27, 2018. No dividends will accrue after September 27, 2018. Each share of Series A Preferred Stock automatically converted into Common Stock on a 20.728-for-one basis upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date. All of these securities are owned by AstraZeneca AB, which is a wholly-owned subsidiary of AstraZeneca PLC. AstraZeneca PLC may be deemed to beneficially own the shares held by AstraZeneca AB, but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any. The principal business address of AstraZeneca AB is SE-151 85 Sodertalje, Sweden. /s/ Adrian Kemp, Company Secretary of AstraZeneca PLC 2018-10-02 /s/ Yvonne Bertlin, Authorized Signatory of AstraZeneca AB 2018-10-02